Biosimilar Newsletter Archive

  1. 12.10.20 -- Why Severability Should Be In Your Biosimilar Vocabulary 12/10/2020
    12/10/20 Biosimilar Development Newsletter
  2. 12.08.20 -- New Podcast Episodes: 2021 Trends For Biotech, Modulation Of The Microbiome And Biopharma Financing 12/8/2020
    12/08/20 Biosimilar Development Newsletter
  3. 12.03.20 -- 3 Perspectives On Biosimilars & Biobetter Development 12/3/2020
    12/03/20 Biosimilar Development Newsletter
  4. 11.25.20 -- Biosimilar Or Biobetter? Perspectives On An Evolving Market 11/25/2020
    11/25/20 Biosimilar Development Newsletter
  5. 11.20.20 -- It's Never Too Early To Think About Automation 11/20/2020
    11/20/20 Biosimilar Development Newsletter
  6. 11.19.20 -- IQVIA's U.S. Biosimilar Report: Your Most Pressing Questions Answered 11/19/2020
    11/19/20 Biosimilar Development Newsletter
  7. 11.12.20 -- The Little-Known Drivers Behind 2020's Biosimilar Boom 11/12/2020
    11/12/20 Biosimilar Development Newsletter
  8. 11.10.20 -- How To Predict And Prepare For Illusive Cell Therapy Issues 11/10/2020
    11/10/20 Biosimilar Development Newsletter
  9. 11.06.20 -- Strategies To Accelerate Process Development 11/6/2020
    11/06/20 Biosimilar Development Newsletter
  10. 11.05.20 -- Biosimilar Manufacturing: The Past, Present, & Future 11/5/2020
    11/05/20 Biosimilar Development Newsletter